Parinya Konyoung

Udon Thani, 41000, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Genetic Variants Associated with Non-Steroidal Anti-Inflammatory Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Genetic Variants Associated with Non-Steroidal Anti-Inflammatory Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Journal: Medical sciences (Basel, Switzerland)

Published: January 16, 2026

Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study.

Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study.

Journal: Clinical rheumatology

Published: October 26, 2025

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions.

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions.

Journal: Frontiers in pharmacology

Published: June 27, 2023

Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.

Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.

Journal: Drug metabolism and pharmacokinetics

Published: May 11, 2022

Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.

Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.

Journal: British journal of clinical pharmacology

Published: May 04, 2021

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.

Journal: Frontiers in immunology

Published: January 30, 2021

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.

Journal: The Journal of allergy and clinical immunology

Published: March 27, 2020

Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.

Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.

Journal: Clinical pharmacology and therapeutics

Published: December 10, 2019

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population.

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population.

Journal: Frontiers in genetics

Published: May 08, 2018

The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

Journal: Clinical pharmacology and therapeutics

Published: November 20, 2017

Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.

Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.

Journal: Journal of immunology research

Published: July 24, 2017

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.

Journal: Pharmacogenetics and genomics

Published: May 17, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026